1. Adams EJ, Asua J, Conde Olasagasti JG, Erlichman M, Flynn K, Hurtado-Saracho I (1999) Positron emission tomography: experience with PET and synthesis of the evidence. On behalf of INAHTA, Stockholm: International Network of Agencies for Health Technology Assessment
2. AETMIS Agence d'évaluation des technologies et des modes d'intervention en santé (2001) La tomographie par emission de positrons au Quebec. Rapport préparé par F.P. Dussault, Van H. Nguyen et F. Rachet (AETMIS 01-3 RF). Montreal: AETMIS (
http://www.aetmis.gouv.qc.ca/fr/publications/scientifiques/imagerie_medicale/2001_03_aann_fr.pdf
)
3. Bourguet P, Blanc-Vincent MP, Boneu A, Bosquet L, Chauffert B, Corone C, Courbon F, Devillers A, Foehrenbach H, Lumbroso JD, Mazselin P, Montravers F, Moretti JL, Talbot JN (2003) 2002 Standards, Options and Recommandations for use of positrons emission tomography with [18F]-FDG in oncology. Bull Cancer 90: S1–S109
4. Fervers B, Hardy J, Blanc-Vincent MP, Theobald S, Bataillard A, Farsi F, Gory G, Debuiche S, Guillo S, Renaud-Salis JL, Pinkerton R, Bey P, Philip T (2001) SOR: project methodology. Br J Cancer 84 (Suppl 2), 8–16
5. Reske SN, Kotzerke J (2001) FDG-PET for clinical use. Results of the third German Interdisciplinary Consensus Conference, ‘Onko-PET III’, 21 July: and 19 September 2000. Eur J Nucl Med 28: 1707–1723